Understanding Ozempic Eligibility: How Much Do You Need to Weigh?

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people ask whether there's a minimum weight requirement for semaglutide therapy, but the answer is more nuanced than a simple number. The FDA's guidance focuses on body mass index (BMI) and existing weight-related medical conditions rather than absolute weight, meaning eligibility depends on your individual health picture.

BMI Requirements for Semaglutide Treatment

Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or higher who have at least one weight-related condition like hypertension, type 2 diabetes, or heart disease—or a BMI of 30 kg/m² or higher regardless of other conditions. Your BMI is calculated by dividing your weight in kilograms by your height in meters squared, and this metric serves as the clinical starting point for eligibility screening. However, BMI alone doesn't tell the whole story, as it doesn't account for muscle mass, bone density, or where your body stores fat.

PlexusDx evaluates candidates based on their complete medical history rather than weight alone. A person with a BMI of 28 kg/m² and type 2 diabetes may qualify, while someone with a BMI of 32 kg/m² and no weight-related conditions might be better served by lifestyle interventions first. Your age, medication history, and metabolic markers all factor into whether compounded semaglutide injection is the right therapeutic choice.

Weight-Related Health Conditions That Increase Eligibility

If you have a BMI between 27 and 30 kg/m², the presence of weight-related comorbidities significantly strengthens your eligibility case. Hypertension, type 2 diabetes, cardiovascular disease, sleep apnea, and non-alcoholic fatty liver disease are established weight-sensitive conditions that medical providers use to justify semaglutide therapy at lower BMI thresholds. Clinical trials have shown that GLP-1 receptor agonists improve blood sugar control and reduce cardiovascular events, making them valuable tools for patients whose excess weight compounds existing health risks.

Semaglutide's mechanism—slowing gastric emptying and activating brain circuits that regulate appetite—addresses the biological drivers of weight gain rather than relying on willpower alone. PlexusDx providers review your complete medical record, including blood pressure readings, glucose levels, and imaging studies, to confirm whether weight-related conditions justify initiating treatment at your current BMI.

No Minimum Weight Threshold—Individual Assessment Matters

Unlike some misconceptions circulating online, there is no absolute minimum weight you must reach or exceed to be eligible for semaglutide. Instead, medical guidelines emphasize that eligibility is determined individually based on BMI classification, the presence of metabolic complications, and your overall risk profile. A 25-year-old with a BMI of 28 kg/m² and newly diagnosed prediabetes has a stronger case for therapy than a 45-year-old with a BMI of 35 kg/m² who is metabolically healthy and motivated by appearance alone.

PlexusDx takes a precision-health approach, meaning your compounded semaglutide injection therapy is tailored to your unique metabolic needs. The Precision Peptide Genetic Test, available as a $99 add-on, analyzes your genetic predisposition across 49 peptides and 14 metabolic pathways—including variants in the GLP1R and FTO genes—to confirm whether GLP-1 receptor activation aligns with your biology. This personalized insight helps your provider choose the optimal starting dose and predict your likely response pattern.

How PlexusDx Determines Your Semaglutide Eligibility

When you start a consultation with PlexusDx, the clinical team reviews your current weight, height, BMI, medical history, active medications, and any existing weight-related diagnoses. You'll provide information about previous weight-loss attempts, family history of obesity or diabetes, and any cardiovascular or metabolic concerns. This comprehensive intake ensures that your compounded semaglutide injection prescription—starting at $149/mo—is appropriate and safe for your circumstances, and that you understand realistic timelines for results.

PlexusDx compounds all medications through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the brand-name price tag. Your dose may need to go up as your body responds and adapts, but your monthly price won't change. The service is available in all 50 states with no insurance required, and your treatment plan can be adjusted based on clinical response and genetic insights from optional peptide testing.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is there a minimum weight I need to be to qualify for semaglutide?

No single minimum weight exists—eligibility is based on BMI (27 kg/m² with weight-related conditions, or 30 kg/m² regardless). PlexusDx evaluates your individual health profile, including existing metabolic complications and medical history, to confirm you're a candidate for compounded semaglutide injection.

What if my BMI is 28 but I don't have diabetes or high blood pressure?

A BMI between 27 and 30 kg/m² generally requires at least one documented weight-related condition for standard eligibility. However, some providers may consider other factors like family history, previous weight regain, or early markers of metabolic dysfunction. PlexusDx reviews your complete clinical context during your consultation.

Can I get semaglutide compounded by PlexusDx if I'm in my 60s and overweight?

Yes, age alone does not disqualify you. PlexusDx serves patients across all age groups and evaluates older adults for semaglutide therapy using the same BMI and comorbidity criteria. Your provider will assess kidney and liver function to ensure safe dosing, as these organs naturally change with age.

How much does compounded semaglutide cost at PlexusDx?

Compounded semaglutide injection starts at $149/mo across all commitment tiers—your dose may increase over time, but your price stays the same. PlexusDx serves all 50 states without requiring insurance, and your treatment is HSA/FSA eligible.

How does the Precision Peptide Genetic Test improve my eligibility assessment?

The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes your variants in the GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways. This genetic insight confirms whether GLP-1 receptor activation aligns with your biology and helps your PlexusDx provider optimize your compounded semaglutide dose for maximum efficacy.

Related Reading

• What Genetic Factors Determine How Much Sleep You Need Each Night
• Does My Dna Affect How Much Sleep I Need For Mental Clarity
• Genetic Testing 101 What You Need To Know Before Getting Tested
• Lifemd Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.